» Articles » PMID: 34413901

Invisible Steps for a Global Endemy: Molecular Strategies Adopted by

Overview
Publisher Sage Publications
Specialty Gastroenterology
Date 2021 Aug 20
PMID 34413901
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

infection (CDI) is on the rise worldwide and is associated with an increase in deaths and socio-health burden. has become ubiquitous in anthropized environments because of the extreme resistance of its spores. Based on the epidemiological data and knowledge of molecular pathogenesis of , it is possible to predict its progressive colonization of the human population for the following reasons: first, its global spread is unstoppable; second, the toxins (Tcds) produced by , TcdA and TcdB, mainly cause cell death by apoptosis, but the surviving cells acquire a senescence state that favours persistence of in the intestine; third, proinflammatory cytokines, tumour necrosis factor-α and interferon-γ, induced during CDI, enhance the cytotoxicity of Tcds and can increase the survival of senescent cells; fourth, Tcds block mobility and induce apoptosis in immune cells recruited at the infection site; and finally, after remission from primary infection or relapse, causes functional abnormalities in the enteric glial cell (EGC) network that can result in irritable bowel syndrome, characterized by a latent inflammatory response that contributes to survival and enhances the cytotoxic activity of low doses of TcdB, thus favouring further relapses. Since a 'global endemy' of seems inevitable, it is necessary to develop an effective vaccine against Tcds for at-risk individuals, and to perform a prophylaxis/selective therapy with bacteriophages highly specific for We must be aware that CDI will become a global health problem in the forthcoming years, and we must be prepared to face this menace.

Citing Articles

TRPV4 modulates inflammatory responses and apoptosis in enteric glial cells triggered by Clostridioides difficile toxins A and B.

Pacifico D, Costa D, Lima Barbosa M, Reboucas C, Simonato S, Warren C J Inflamm (Lond). 2025; 22(1):3.

PMID: 39810162 PMC: 11731189. DOI: 10.1186/s12950-024-00425-7.


Gene Expression Dysregulation in Whole Blood of Patients with Infection.

Tsakiroglou M, Evans A, Doce-Carracedo A, Little M, Hornby R, Roberts P Int J Mol Sci. 2024; 25(23).

PMID: 39684365 PMC: 11641058. DOI: 10.3390/ijms252312653.


PhosphoLipidome Alteration Induced by Toxin B in Enteric Glial Cells.

Buratta S, Urbanelli L, Pellegrino R, Alabed H, Latella R, Cerrotti G Cells. 2024; 13(13.

PMID: 38994956 PMC: 11240607. DOI: 10.3390/cells13131103.


Clostridioides Infection: Landscape and Microbiome Therapeutics.

Gawey B, Khanna S Gastroenterol Hepatol (N Y). 2023; 19(6):319-328.

PMID: 37706187 PMC: 10496268.


Role of the Alteration in Calcium Homeostasis in Cell Death Induced by Toxin A and Toxin B.

Fettucciari K, Dini F, Marconi P, Bassotti G Biology (Basel). 2023; 12(8).

PMID: 37627001 PMC: 10452684. DOI: 10.3390/biology12081117.


References
1.
Aktories K, Schwan C, Jank T . Clostridium difficile Toxin Biology. Annu Rev Microbiol. 2017; 71:281-307. DOI: 10.1146/annurev-micro-090816-093458. View

2.
Shen E, Zhu K, Li D, Pan Z, Luo Y, Bian Q . Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B. Commun Biol. 2020; 3(1):347. PMC: 7335066. DOI: 10.1038/s42003-020-1078-y. View

3.
Loo V, Bourgault A, Poirier L, Lamothe F, Michaud S, Turgeon N . Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011; 365(18):1693-703. DOI: 10.1056/NEJMoa1012413. View

4.
Kurti Z, Lovasz B, Mandel M, Csima Z, Golovics P, Csako B . Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol. 2015; 21(21):6728-35. PMC: 4458783. DOI: 10.3748/wjg.v21.i21.6728. View

5.
Furuya-Kanamori L, Marquess J, Yakob L, Riley T, Paterson D, Foster N . Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis. 2015; 15:516. PMC: 4647607. DOI: 10.1186/s12879-015-1258-4. View